Barclays Maintains Overweight on Acadia Healthcare Co, Lowers Price Target to $89
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on Acadia Healthcare Co (NASDAQ:ACHC) but lowers the price target from $91 to $89.
May 15, 2024 | 12:40 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays analyst Andrew Mok maintains an Overweight rating on Acadia Healthcare Co (NASDAQ:ACHC) but lowers the price target from $91 to $89.
The Overweight rating suggests a positive outlook, but the slight reduction in the price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100